Bowen' s disease is in situ squamous carcinoma of the skin, mostly affecting sun-exposed areas of the body. There are many options in the treatment of Bowen' s disease, with varying success rates. Five-fluorouracil (5-FU) inhibits DNA synthesis and causes death of tumor cells by targeting rapidly proliferating cells. Topical 5-FU has been used effectively in the treatment of Bowen' s disease. The current report describes case of giant neglected Bowen' s disease lesion in a male patient, which was successfully treated with 5-fluorouracil therapy.
A 62-year-old male patient presented at our clinic complaining of erythema and scaling. The patient had lesion that had enlarged over course of 7 years. Dermatological examination revealed infiltrative red-brown plaque with oval-round shape and welldefined and irregular margins on left lateral side of the body, measuring 13x13 cm in size with patchy crust and scaling ( Figure 1A) . Histopathological examination of punch biopsy material demonstrated disruption of polarity in all layers of epidermis, mildmoderate atypia, multiple dyskeratotic cells, increased mitotic activity, and moderate-severe mononuclear infiltration in the upper layer of dermis. Integrity of basement membrane was preserved without invasion ( Figure 1B) . The patient was diagnosed with Bowen' s disease and treatment with topical 5-FU 5% applied twice daily was initiated. Skin ulcer developed at the site of plaque lesion 1 month after initiation of therapy, and therefore therapy was discontinued. Two months after cessation of therapy, infiltrated plaque had disappeared and lesion showed near-complete regression ( Figure 1C ). Skin biopsy materials obtained from 3 different areas at the site of plaque lesion 1 year after therapy indicated that epidermal atypia had completely disappeared, polarity had been restored, and there was no finding in favor of Bowen' s disease ( Figure 1D ). Clinicians should not overlook effective nonsurgical treatment methods, such as topical 5-FU, in cases of Bowen' s disease.
